PRRT2 and cancer: The protein kinase C (PKC) family, first discovered in 1977 by Takai et al. [1], includes distinctive phospholipid-dependent enzymes able to phosphorylate the Ser and Thr residues of many substrates involved in either the promotion or suppression of cancer.